Long Acting Injectable Anti Psychotic Market Report

Market Insights

The Long-Acting Injectable Anti-Psychotic Market is expected to grow at a healthy CAGR during the forecast period.

Figure: Long-Acting Injectable Anti-Psychotic Market Size, 2020-2026 (USD Million)

Wish to know more about the market assumptions? Click here to get a free sample.

What are Long-Acting Injectable Antipsychotics?

Anti-psychotic is a type of medication primarily used to manage psychosis which includes hallucinations, delusion, and paranoia in various psychotic disorders. Long-acting injectable (LAI) antipsychotic is primarily used to treat patients having schizophrenia disorder. It can be taken every two to four weeks or every three months instead of consuming pills on a daily basis.

Key Players

Key players operating in the global Long-Acting Injectable Anti-Psychotic Market are-

• Johnson & Johnson (The U.S),
• Eli Lily and Company (The U.S),
• Alkeremes Public Limited Company (Ireland),
• H. Lundbeck A/S (Denmark),
• Pfizer Inc. (The U.S),
• GlaxoSmithKline plc (UK),
• Lupin Limited (India),
• MedinCell S.A. (France),
• Zogenix (The U.S), and
• Durect Corporation (The U.S).

Market Dynamics

Rising demand for advanced healthcare solutions coupled with increasing health awareness is likely to add to the market growth substantially.

• The growth of the global long-acting injectable anti-psychotic market is primarily driven by an increasing number of people suffering from schizophrenia. It is diagnosed more frequently in males as compared to females.

• Growing preference for long-acting injectable anti-psychotics over oral medications for people suffering from mental disorders is likely to propel the market growth at a significant rate during the review period.

• However, the side effects of taking long-acting injectable anti-psychotics are likely to affect the market growth negatively.

COVID-19 Impact 

The COVID-19 outbreak did not affect the growth of the long-acting injectable anti-psychotic market. The national healthcare organizations in many European countries and the US allowed the ongoing usage of long-term injectable anti-psychotics for patients suffering from mental disorders and having high-risk chronic illnesses. The majority of mental healthcare facilities allowed the continuation of visits as it is an essential clinical procedure.

Segment Analysis

Application Trends

Based on application, the market has been segmented into schizophrenia and others. The schizophrenia segment accounted for the largest market share in 2020 and is projected to grow at the fastest CAGR during the review period. The segment growth can be attributed to the rising incidence of people suffering from schizophrenia. Schizophrenia is a serious mental disorder in which people abnormally infer reality.

Regional Trends

Geographically, the market in North America accounted for the largest market share in 2020. The regional market growth can be attributed to the increasing number of people suffering from mental disorders coupled with the expanding geriatric population and the presence of established healthcare infrastructure.  The market in Asia-Pacific is expected to register the fastest growth during the review period on account of rising consumer awareness and increasing spending on healthcare.

Want to know the full scope of the report? Register Here

Target Audience

The following is a list of the customers that the Global Long-Acting Injectable Anti-Psychotic market aims to convert the most:

• Long-acting injectable anti-psychotic manufacturers
• Long-acting injectable anti-psychotic suppliers
• Long-acting injectable anti-psychotic distributors
• Organizations
• Government bodies

Critical Questions Answered in the Report

• What are the key trends in the global long-acting injectable anti-psychotic market?
• How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
• What is the impact of COVID-19 on the global long-acting injectable anti-psychotic market?
• What are the key strategies adopted by the major vendors to lead in the global long-acting injectable anti-psychotic market?
• What is the market share of the top vendors?

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.